These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 18256129)

  • 1. Electrophysiological effects of angiotensin II. Part I: signal transduction and basic electrophysiological mechanisms.
    Goette A; Lendeckel U
    Europace; 2008 Feb; 10(2):238-41. PubMed ID: 18256129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gap junctions in preconditioning against arrhythmias.
    Lascano EC; Negroni JA
    Cardiovasc Res; 2007 Jun; 74(3):341-2. PubMed ID: 17459356
    [No Abstract]   [Full Text] [Related]  

  • 3. Phosphoinositide signalling and cardiac arrhythmias.
    Woodcock EA; Kistler PM; Ju YK
    Cardiovasc Res; 2009 May; 82(2):286-95. PubMed ID: 18940816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adhesion molecules: why they are important to the electrophysiologist.
    Saffitz JE
    J Cardiovasc Electrophysiol; 2006 Feb; 17(2):225-9. PubMed ID: 16533266
    [No Abstract]   [Full Text] [Related]  

  • 5. [Anesthesia and cardiac electrophysiology (Part I)].
    Zaballos García M; Almendral Garrote J; Navia Roque J
    Rev Esp Anestesiol Reanim; 2005 May; 52(5):276-89; quiz 289-90, 294. PubMed ID: 15968906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypertension and cardiac arrhythmias: a review of the epidemiology, pathophysiology and clinical implications.
    Yiu KH; Tse HF
    J Hum Hypertens; 2008 Jun; 22(6):380-8. PubMed ID: 18337759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin II: a hormone involved in and contributing to pro-hypertrophic cardiac networks and target of anti-hypertrophic cross-talks.
    Schlüter KD; Wenzel S
    Pharmacol Ther; 2008 Sep; 119(3):311-25. PubMed ID: 18619489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Signaling mechanisms coupled to the angiotensin receptor of proximal tubular epithelium.
    Douglas JG; Romero M; Hopfer U
    Kidney Int Suppl; 1990 Nov; 30():S43-7. PubMed ID: 1701838
    [No Abstract]   [Full Text] [Related]  

  • 9. The intracellular renin-angiotensin system: implications in cardiovascular remodeling.
    Kumar R; Singh VP; Baker KM
    Curr Opin Nephrol Hypertens; 2008 Mar; 17(2):168-73. PubMed ID: 18277150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The safety role of gap junctions: a new perspective on atrio-ventricular nodal reentry.
    Mahdavi S; Gharibzadeh S; Towhidkhah F; Rezaei-Tavirani M
    Med Hypotheses; 2006; 67(5):1253-4. PubMed ID: 16828982
    [No Abstract]   [Full Text] [Related]  

  • 11. Electrophysiologic remodeling: what happens to gap junctions?
    Saffitz JE
    J Cardiovasc Electrophysiol; 1999 Dec; 10(12):1684-7. PubMed ID: 10636198
    [No Abstract]   [Full Text] [Related]  

  • 12. Putative druggable targets for selective enhancement of cardiac conduction.
    Gomes J; Lambiase PD
    Curr Opin Pharmacol; 2009 Apr; 9(2):154-9. PubMed ID: 19109070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Newly developed angiotensin II-infused experimental models in vascular biology.
    Qin Z
    Regul Pept; 2008 Oct; 150(1-3):1-6. PubMed ID: 18562020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin II and the development of insulin resistance: implications for diabetes.
    Olivares-Reyes JA; Arellano-Plancarte A; Castillo-Hernandez JR
    Mol Cell Endocrinol; 2009 Apr; 302(2):128-39. PubMed ID: 19150387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phospholipase C/protein kinase C pathway mediates angiotensin II-dependent apoptosis in neonatal rat cardiac fibroblasts expressing AT1 receptor.
    Vivar R; Soto C; Copaja M; Mateluna F; Aranguiz P; Muñoz JP; Chiong M; Garcia L; Letelier A; Thomas WG; Lavandero S; Díaz-Araya G
    J Cardiovasc Pharmacol; 2008 Aug; 52(2):184-90. PubMed ID: 18670360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin II up-regulates PAX2 oncogene expression and activity in prostate cancer via the angiotensin II type I receptor.
    Bose SK; Gibson W; Giri S; Nath N; Donald CD
    Prostate; 2009 Sep; 69(12):1334-42. PubMed ID: 19517575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aldosterone and angiotensin II synergistically stimulate migration in vascular smooth muscle cells through c-Src-regulated redox-sensitive RhoA pathways.
    Montezano AC; Callera GE; Yogi A; He Y; Tostes RC; He G; Schiffrin EL; Touyz RM
    Arterioscler Thromb Vasc Biol; 2008 Aug; 28(8):1511-8. PubMed ID: 18467645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Remodelling of cardiac repolarization: how homeostatic responses can lead to arrhythmogenesis.
    Michael G; Xiao L; Qi XY; Dobrev D; Nattel S
    Cardiovasc Res; 2009 Feb; 81(3):491-9. PubMed ID: 18826964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Physiological role of angiotensin II and IV as active components of the renin-angiotensin system].
    Prozherina IuA
    Zh Vyssh Nerv Deiat Im I P Pavlova; 2008; 58(6):649-62. PubMed ID: 19178068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toward specific cardiac I(K1) modulators for in vivo application: old drugs point the way.
    van der Heyden MA; Sánchez-Chapula JA
    Heart Rhythm; 2011 Jul; 8(7):1076-80. PubMed ID: 21296684
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.